Skip to main content

NYSE Euronext, Taiwan Futures Exchange Partner for Two-Way Order Routing

taiwan
Taiwan Futures Exchange and NYSE Euronext will share information and resources henceforth.

The partnership includes two-way order routing between the exchanges and the sharing of information and resources regarding product innovation and best practices.

"Taiwan is a major trading market for futures and options in Asia, and as a group NYSE Euronext is actively seeking strategic opportunities that enhance our regional footprint," says Dominique Cerutti, president and deputy CEO, NYSE Euronext.

Steve Wang, president of Taiwan Futures Exchange, adds: "In response to the rapidly changing global financial landscape, collaboration between exchanges has become increasingly important. We believe Taiwan Futures Exchange and NYSE Euronext will leverage unique knowledge from each other's market, and the partnership facilitating the future cross-border arrangement will benefit both exchanges and better serve the markets."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Market data costs defy cyclicality

Trading firms continue to grapple with escalating market data costs. Can innovative solutions and strategic approaches bring relief?

AI & data enablement: A looming reality or pipe dream?

Waters Wrap: The promise of AI and agents is massive, and real-world success stories are trickling out. But Anthony notes that firms still need to be hyper-focused on getting the data foundation correct before adding layers.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here